Sildenafil for Vascular Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
Contemporary left ventricular assist device (LVAD) therapy improves survival during advanced heart failure but vascular aging develops rapidly leading to major adverse events including stroke and bleeding in nearly half of patients. In this study, the study team aims to investigate whether sildenafil pharmacotherapy, which has anti-fibrotic effects, can reduce vascular aging during LVAD support. An aim of this study is to compare changes in small blood vessels in the gastrointestinal tract between participants receiving sildenafil or placebo. Video capsule endoscopy (VCE) will be used to assess these changes in small blood vessels.
Do I need to stop my current medications for the trial?
If you are taking any nitric oxide (NO) donor medications, you will need to stop them to participate in this trial.
Is sildenafil safe for use in humans?
Sildenafil, known by various brand names like Viagra and Revatio, is generally considered safe for most people, but it should not be used with nitrates (medications for chest pain) as this can cause a dangerous drop in blood pressure. Some reports have noted heart-related issues, especially in those with existing heart conditions, so it's important to consult a doctor if you have heart disease.12345
How is the drug sildenafil unique for treating vascular disease?
Sildenafil is unique for treating vascular disease because it not only helps with erectile dysfunction and pulmonary hypertension but also shows promise in protecting the heart from damage due to reduced blood flow and other cardiovascular issues. It works by inhibiting an enzyme called phosphodiesterase-5, which helps relax blood vessels and improve blood flow.46789
What data supports the effectiveness of the drug sildenafil for vascular disease?
Sildenafil, known for treating erectile dysfunction, has shown promise in improving heart health by protecting against heart damage and lowering blood pressure in certain conditions. It is also effective in treating pulmonary arterial hypertension, a type of high blood pressure affecting the lungs.46101112
Who Is on the Research Team?
Omar Saeed, MD
Principal Investigator
Montefiore Medical Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are receiving durable left ventricular assist device (LVAD) support and can give informed consent. It's not suitable for those with a pre-existing aortic valve prosthesis or graft, allergy to sildenafil, complete carotid occlusion, or those taking nitric oxide donor medications.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive sildenafil or placebo to assess vascular remodeling during LVAD support
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Sildenafil
Sildenafil is already approved in United States, European Union, Canada, Japan for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montefiore Medical Center
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator